In Episode 12 Heather and Lee talk with Dr. Beatrice Golomb of the Golomb Research Group about Gulf War Illness, attitudes of which have been “one of the disgraces of modern medicine.” They discuss the multi-symptom-related health problems suffered by Gulf War Veterans. These health problems are likely a result of mitochondria damage and oxidative stress caused by chemical exposures and toxicities, including Pyridostigmine Bromide (PB), fluoroquinolones and nerve gases such as Sarin.

In this episode, Heather and Lee talk with author Andrew Marriott about his firsthand experience in

In the third of three mini-episodes, Heather and Lee recap lessons learned from previous guests Dr. David Healy and Dr. Charles Bennett, and look ahead to forthcoming episodes with Andrew Marriott and Dr. Beatrice Golomb.

In the second of three mini-episodes, Heather and Lee recap lessons learned from previous guests Dr. David Healy and Dr. Charles Bennett, and look ahead to forthcoming episodes with Andrew Marriott and Dr. Beatrice Golomb.

In the first of three mini-episodes, Heather and Lee recap lessons learned from previous guests Dr. David Healy and Dr. Charles Bennett, and look ahead to forthcoming episodes with Andrew Marriott and Dr. Beatrice Golomb.

Meet Dana and Ferdi, who were brought together across continents by an adverse drug reaction to fluoroquinolone antibiotics (ciprofloxacin, moxifloxacin, levofloxacin and ofloxacin) that left them disabled. In spite of it all, they found love and the strength to assist other victims struggling with fluoroquinolone toxicity.

On this episode Dr. Charles Bennett joins Heather and Lee to discuss the forthcoming book, Taking On Big Pharma: Dr. Bennett’s Battle; black box warnings; citizens petitions; and his recent journal article, “Davids versus Goliaths,” where he talks about his story and that of 26 others and how they were retaliated against for reporting on drug safety, effectiveness, and data integrity concerns.

Heather and Lee are joined again by Dr. David Healy. We discuss akathisia — what it is, who it affects, and what to watch for, as well as a range of consequences for this treatment-induced harm.

Find the full episode transcript at https://www.knowrisks.org/episode5.

Join Heather and Lee for an informative discussion with Dr. David Healy highlighting the fraudulent tactics of industry and health care in hiding the data and marketing the “science.” The conversation addresses the processes of drug approval research, what’s changed, who’s doing the writing, and what data is being used?

Visit the main podcast page: www.knowrisks.org/podcast. There you can link to a full transcript of the episode.

Join Heather and Lee’s discussion with Dr. David Healy highlighting randomized controlled trials, why you can’t always trust the “science,” and the importance of your hunch or gut feeling when treatment goes wrong and how it’s your best guide to avoid unnecessary harm.

Dr. David Healy is a world-renowned psychiatrist, psychopharmacologist, neuropsycopharmacologist, scientist, and author. He undertook his doctoral research on the serotonin system on which antidepressants work, while qualifying in psychiatry.  He moved to Cambridge University for higher training in psychiatry and to engage in post-doctoral research.  

He has since been a Professor of Psychiatry in Cardiff University and Bangor University, working clinically in the NHS for 30 years, before recently being appointed as a professor of Psychiatry in the Department of Family Medicine at McMaster University in Canada.

His main area of research includes the contribution of psychotropic drugs to suicide, for which he was one of the very first researchers to make this link; the adverse effects of these drugs; the conflicts of interest between pharmaceutical companies and academic medicine; and the history of pharmacology.

He has published 25 books on medicine, primarily on physical treatments and the development of the pharmaceutical industry, including the standard histories of antidepressants, antipsychotics, and mood-stabilizers.  He has authored over 60 chapters in books on similar issues, over 200 peer-reviewed articles, and over 250 other pieces, for the most part dealing with the impact of medicines on health care. 

He has been involved in numerous legal cases, centered primarily on the harms of treatment.  He has acted as an expert in numerous cases in the United States involving suicide and psychotropic drugs, and he has publicly and internally provided testimony and consultation to the Food and Drug Administration (FDA) regarding psychotropic drugs and their effects.